AI-enabled, family-powered autism therapy company Forta announced it closed a $55 million Series A funding round led by Insight Partners.
Alumni Ventures and Exor Ventures also participated in the round, as well as the founders of Forward, Flexport, Curative, 23&Me, Prelude Fertility, Warby Parker, Harry's and Allbirds.
WHAT IT DOES
Forta combines AI and LLMs with a 50-hour training course...
SpectrumAi, a startup focused on autism care, announced it raised up to $20 million in a Series A funding round led by CVS Health Ventures with participation from Cobalt Ventures.
Previous investors Frist Cressey, F-Prime and Autism Impact Fund also participated in the raise.
WHAT IT DOES
The Los Angeles-based company offers tools to help analyze quality and outcomes data on applied behavior...
EarliTec Diagnostics announced it has received FDA 510(k) clearance for a device that helps clinicians identify autism spectrum disorder for children between the ages of 16 and 30 months old.
The tool, called EarliPoint Evaluation, uses eye-tracking technology to monitor a child's looking behavior while they watch short videos of other children interacting with one another. The technology...
Pediatric behavioral health platform Brightline will launch a program for children with autism spectrum disorder in early 2022.
The company will also expand content and coaching geared toward youth who identify as LGBTQ, and Black, Indigenous or other children of color, expected to be available early next year. Brightline announced a Clinical Advisory Board that aims to help develop more programs...
Techcyte raised $21 million in funding for its digital clinical pathology platform. Zoetis, an animal healthcare company and drugmaker, and ARUP Laboratories participated in this round of funding, plus investors from previous rounds.
“Our relationship with Zoetis has been incredible as we’ve revolutionized diagnostics for veterinary clinics,” Ben Cahoon, CEO of Techcyte, said in a statement. “...
Pediatric behavioral health company Cognoa has received FDA De Novo classification for its autism spectrum disorder (ASD) software diagnostic aid, Canvas Dx.
The ASD diagnostic tool is designed to help primary care clinicians and pediatricians evaluate and diagnose suspected cases of autism among children. It uses machine learning algorithms to analyze videos of the child’s behavior and responses...
Springtide, a multimodal clinic for children with developmental delays, today announced the closing of its Series A equity round worth $18.1 million.
Deerfield Management Company and Optum Ventures led the round. Along with their monetary contribution, representatives from each company will join Springtide’s board of directors to provide strategic guidance and support.
WHAT IT DOES
With offices...
Cognoa, a digital health company developing software tools for children with autism and other behavioral health conditions and their families, signaled today that it will be moving ahead with a De Novo FDA regulatory submission for its digital autism spectrum disorder (ASD) diagnostic.
The tool, which received a Breakthrough Device Designation from the agency in late 2018, is designed to help...
Editor's note: This story has been updated with the timing and size of the pilot.
Scottsdale, Arizona-based Magellan Health announced today that it has launched a pilot of Boston Children's Hospital spin-out Neuromotion Labs' Mightier, a biofeedback video game platform designed to help children regulate their emotions.
Since June 22, the managed care company has begun supplying members with...
This morning Sprout, a tech-enabled autism care and treatment program, launched its service on the back of $10 million in seed funding from institutional investors General Catalyst, Bling Capital and Felicis Ventures.
WHAT THEY DO
Sprout's approach combines prompt in-home assessments and applied behavior analysis (ABA) therapy from a live therapist with a tech platform that delivers ongoing...
